[Revealed] Trump's Next AI Executive Orders?
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Financials
| Curr Year EPS Estimate | -4.78 |
| Next Quarter EPS Estimate | -1.19 |
| Profit Margin | -26568.53% |
| Operating Margin | -30,392.17 |
| Return on Assets | -0.24 |
| Return on Equity | -0.37 |
| Revenue | 1.4M |
| Earnings Per Share | -3.72 |
| Revenue Per Share | 0.02 |
| Gross Profit | -244,626,000 |
| Quarterly Revenue Growth | 1.58 |
General
| Name | Crinetics Pharmaceuticals Inc |
| Ticker | CRNX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 437 |
About Crinetics Pharmaceuticals Inc
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and cushing's disease; and CRN09682, a nonpeptide drug conjugate for SST2 positive solid tumors. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease; SST3 Agonist program for the treatment for autosomal dominant polycystic kidney disease; and Radionetics for multiple solid-tumors, as well as Oral GLP-1 and Oral GIP nonpeptides for the treatment of obesity. The company has an agreement with Sanwa Kagaku Kenkyusho Co., Ltd to develop and commercialize Paltusotine in Japan, and Cellular Longevity, Inc. to develop and commercialize CRN01941, a somatostatin receptor type 2 agonist. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
Earnings
Embed-Charts-China-Trade-Soybean Farmers, ADVISORY
CHINA-TRADE-SOYBEAN FARMERS — Charts. The following digital embeds show the trends in soybean exports to China over time. The first embed compares exports trends from the U.S. and Brazil and the second embed shows trends in annual U.S. soybean exports over time to China. These charts are current as of Sept. 25, 2025 and will not update. Source: World Bank, USDA
$1000 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
Alnylam Pharmaceuticals (NASDAQ: ALNY) has outperformed the market over the past 5 years by 10.45% on an annualized basis producing an average annual return of 25.22%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.78 billion.
Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.
Ukraine expects $3.5 billion fund for US weapons to sustain fight against Russia, Zelenskyy says
KYIV, Ukraine (AP) — Ukraine expects there will be around $3.5 billion by next month in a fund to buy weapons from the United States and help sustain its against Russia’s all-out invasion, Ukrainian President Volodymyr Zelenskyy said Wednesday.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Trump's touting of an unproven autism drug surprised many, including the doctor who proposed it
WASHINGTON (AP) — When President Donald Trump's administration announced it would as a new treatment for autism, it came as — including the physician who suggested the idea to the nation’s top health officials.
Democrats plan to force Senate vote on Trump's tariffs on Canada and Brazil
WASHINGTON (AP) — Democrats are planning to force two Senate votes on in the coming weeks, keeping pressure on Senate Republicans as many of them have voiced frustration with the policies.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Lockheed Martin Counters Boeing's F-47 Victory With Cost-Effective F-35 Upgrade Using Sixth-Gen Technology
Lockheed Martin is countering Boeing's F-47 win with a cost-effective F-35 upgrade that integrates sixth-generation tech, aiming to offer 80% of the F-47's capabilities at half the price.
AstraZeneca's Fasenra Falls Short In Smoker's Lung Trial
AstraZeneca's Fasenra misses the primary COPD endpoint while Saphnelo's lupus trial shows significant improvements and consistent safety profiles.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Australia warns social media platforms against age verification for all ahead of a ban on children
MELBOURNE, Australia (AP) — Australian authorities said Tuesday that should not demand age verification for all account holders starting from December, when a having accounts goes into effect in the country.
Bitcoin Struggles Around $112,000, But Here's Why The Bull Run Is Not Over Yet
Bitcoin's (CRYPTO: BTC) is languishing around $112,000, but a prominent trader remains adamant about a strong end to the year.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Larry Summers Warns Trump's Push To Scrap Quarterly Earnings Will Affect How Markets Function: 'Students Don't Like Grades…'
Former Treasury Secretary Lawrence H. Summers warned that Donald Trump's proposal to eliminate quarterly earnings reports would weaken accountability and make markets "function less well."
Kevin O'Leary Once Admitted He Wasn't The Best Dad — But The Shark Gave Himself A '10 Out Of 10' Score In One Key Area
Kevin O'Leary admitted he wasn't always present as a father but said financial stability made him a "10 out of 10" provider, sharing how tough-love lessons with his son and sacrifices echoed by Barack Obama and Mark Cuban highlight the trade-offs between family and success.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Japan's exports to the US continue to fall, hit by Trump's tariffs
TOKYO (AP) — Japan’s exports to the United States plummeted 13.8% in August compared to the same month the previous year, marking the fifth straight month of declines, as auto exports were hit by President Donald Trump’s tariffs.
Bill Gates Shares His Two-Step Secret To Problem-Solving, A Technique He's Used Since Teenage: 'It's Surprisingly Hard'
Bill Gates, the co-founder of Microsoft Corporation (NASDAQ: MSFT), shared his approach to solving problems, including those related to his philanthropic projects.
We've Seen This Before... and It Didn't End Well - Ad
Strange events are unfolding in the global financial system. A monetary reset dubbed the "Mar-a-Lago Accord" is quietly in motion, and the financial elite are already taking protective action. If history is any guide, you could lose up to 40% of your wealth in the next two years. Move your money before it's too late.
Cadillac F1 team announces multi-year partnership with Jim Beam
The new Cadillac F1 team on Wednesday announced a multi-year that makes the American bourbon distiller its official spirits partner.
IBM Stock Jumps 5% After Quantum Computing Breakthrough
Shares of International Business Machines Corporation (NASDAQ: IBM) are up Thursday after the company announced it reached a technological milestone in quantum computin
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
The late Italian fashion designer Giorgio Armani instructs heirs to sell 15% of his empire
MILAN (AP) — After a lifetime of spurning would-be business suitors, the late Italian designer instructed his heirs to sell a 15% minority stake in his vast fashion empire, with priority to the French conglomerate LVMH, the eyewear giant Essilor-Luxottica or the cosmetics company L’Oreal.
Farm Aid celebrates 40 years of supporting family farmers with a concert in Minneapolis
MINNEAPOLIS (AP) — Farm Aid — the annual fundraising concerts launched by and during the farm crisis of the 1980s — celebrates its 40th anniversary on Saturday in Minneapolis.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Trump's Push To Fire Fed Governor Sparks Legal Showdown: 'Era Of Fed Independence Would Be Over'
In court battle, Fed Governor Lisa Cook fights Trump admin's attempt to remove her ahead of interest rate decision.
The number of Americans filing for jobless benefits last week hits 263,000, most in nearly 4 years
WASHINGTON (AP) — U.S. jobless claim applications jumped to their highest level in almost four years last week, the latest sign that the labor market is softening.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Oracle's Big AI Bet Faces Credit Risk, Rating Agency Warns
Oracle (NYSE: ORCL) stock rises as AI deals boost investor confidence. However, Moody's warns of risks in $300B AI contracts with OpenAI.
Hong Kong leader unveils plans to boost economy and nurture emerging industries beyond finance
HONG KONG (AP) — Hong Kong's leader announced plans Wednesday to speed up development of an economic powerhouse near its border with mainland China and nurture industries ranging from artificial intelligence to higher education as the city seeks new economic growth engines to maintain its international competitiveness.
Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad
If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."
Gov. Stein requests $13.5B more from Congress for Hurricane Helene recovery
FLAT ROCK, N.C. (AP) — North Carolina Gov. Josh Stein on Monday requested $13.5 billion more from Congress in recovery aid for almost a year after the historic storm, saying additional help is needed from Washington to address record amounts of damage and to get funds to the region quicker.
Huang Breaks Silence On Beijing Move Targeting Nvidia AI Chips
Nvidia (NASDAQ: NVDA) shares rebounded as CEO Jensen Huang addressed reports of China banning its AI chips.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Nvidia's Market Capitalization Surpasses Canada's GDP, As McKinsey Projects $1.7 Trillion AI Data Center Spend By 2030
Nvidia has become the world's most valuable company with a $4.32 trillion market cap — surpassing Canada's GDP.
Republican leaders reject Democratic health care demands for bill to avoid shutdown
WASHINGTON (AP) — Republican leaders in the House and Senate said Wednesday that they will reject for an immediate , challenging Democrats to vote against a stopgap spending bill that doesn't include them but will keep the government open at the end of the month.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Wind and solar power fuel over one-third of Brazil's electricity for first time
BOGOTA, Colombia (AP) — Wind and generated more than a third of electricity in August, the first month on record the two renewable sources have crossed that threshold, according to government data made public on Thursday and analyzed by energy think tank Ember.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.